Literature DB >> 30621813

Process measure of FAST tuberculosis infection control demonstrates delay in likely effective treatment.

H Le1, N Nguyen2, P Tran3, N Hoa4, N Hung2, A Moran5, H J Al Mossawi5, N Kak5, S Ahmedov6, M B Brooks7, E A Nardell8, D B Tierney8.   

Abstract

SETTING: The tuberculous infection control strategy, FAST (Find cases Actively, Separate safely and Treat effectively), recommends prompt initiation of likely effective anti-tuberculosis treatment informed by Xpert® MTB/RIF results.
OBJECTIVE: To describe FAST implementation at Quang Nam Provincial TB and Lung Disease Hospital (QNH), Tam Ky, Viet Nam, using time to initiation of effective TB treatment as a process measure.
DESIGN: Hospital logs were used to calculate the time to likely effective treatment in patients with pulmonary TB (PTB) hospitalised during the study period.
RESULTS: Between 1 January and 31 December 2016, of 858 patients treated for PTB, 493 (57.5%) received likely effective treatment. The median time to likely effective treatment was 3 days (interquartile range 2.0-6.0), with 213 (43.2%) patients receiving likely effective treatment within 2 days. Of 81 patients receiving likely effective treatment for drug-susceptible TB with a positive Xpert result as their initial in-patient diagnostic test, 64 (79.0%) received likely effective treatment within 2 days compared with 10 (5.7%) who were initially smear-negative then found to be Xpert-positive (P < 0.0001).
CONCLUSIONS: A 'time to' process measure of the FAST tuberculous infection control strategy indicates delays in the initiation of likely effective anti-tuberculosis treatment in a resource-limited hospital. Expanding access to Xpert may speed time to likely effective treatment.

Entities:  

Year:  2019        PMID: 30621813     DOI: 10.5588/ijtld.18.0268

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  2 in total

1.  Host Determinants of Infectiousness in Smear-Positive Patients With Pulmonary Tuberculosis.

Authors:  Carlos Acuña-Villaorduña; Irene Ayakaka; Luiz Guilherme Schmidt-Castellani; Francis Mumbowa; Patricia Marques-Rodrigues; Mary Gaeddert; Laura F White; Moises Palaci; Jerrold J Ellner; Reynaldo Dietze; Moses Joloba; Kevin P Fennelly; Edward C Jones-López
Journal:  Open Forum Infect Dis       Date:  2019-04-11       Impact factor: 3.835

2.  Using hospital auxiliary worker and 24-h TB services as potential tools to overcome in-hospital TB delays: a quasi-experimental study.

Authors:  Miguelhete Lisboa; Inês Fronteira; Paul H Mason; Maria do Rosário O Martins
Journal:  Hum Resour Health       Date:  2020-04-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.